Enochian Biosciences, Inc. ENOB

Full chart Compare
Set alert

Price alert · ENOB

All alert types
0.71 0.00 (+0.00%)

Aug 4, 2023, 3:58 PM EDT

0.70 Day range 0.745
0.393 52-week range 2.99

Financial health

Altman Z-Score

-110.77 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.7×
FY 2017: -29.5×FY 2018: -7.9×FY 2019: -6.7×FY 2020: -16.8×FY 2021: -8.7×FY 2022: -0.9×FY 2023: -0.0×FY 2024: -0.8×FY 2025: -0.6×FY 2026: -0.7×
FY 2017 5y median -0.7× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B -0.0×
FY 2017: 47.2×FY 2018: 0.5×FY 2019: 1.0×FY 2020: 1.2×FY 2021: 1.3×FY 2022: 1.4×FY 2023: 0.1×FY 2024: 0.5×FY 2025: -5.4×FY 2026: -0.0×
FY 2017 5y median 0.1× FY 2026
P/FCF -0.0×
FY 2017: -61.5×FY 2018: -16.7×FY 2019: -18.2×FY 2020: -18.3×FY 2021: -11.3×FY 2022: -6.4×FY 2023: -2.7×FY 2024: -6.1×FY 2025: -14.7×FY 2026: -0.0×
FY 2017 5y median -6.1× FY 2026
EV/EBITDA 0.0×
FY 2017: -28.7×FY 2018: -9.1×FY 2019: -8.6×FY 2020: -17.3×FY 2021: -8.5×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.9×FY 2025: -0.7×FY 2026: 0.0×
FY 2017 5y median -0.0× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -224830.5%
FY 2017: -1.6%FY 2018: -6.0%FY 2019: -5.5%FY 2020: -5.5%FY 2021: -8.8%FY 2022: -15.5%FY 2023: -37.0%FY 2024: -16.4%FY 2025: -6.8%FY 2026: -224830.5%
FY 2017 5y median -16.4% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE 39.5%
FY 2017: -156.1%FY 2018: -5.9%FY 2019: -14.5%FY 2020: -6.9%FY 2021: -15.3%FY 2022: -156.2%FY 2023: -8533818.2%FY 2024: -61.1%FY 2025: 833.8%FY 2026: 39.5%
FY 2017 5y median -61.1% FY 2026
ROIC 113.2%
FY 2017: -71.2%FY 2018: -4.5%FY 2019: -6.1%FY 2020: -6.7%FY 2021: -12.4%FY 2022: -145.8%FY 2023: -8073129.5%FY 2024: -60.1%FY 2025: 1690.8%FY 2026: 113.2%
FY 2017 5y median -60.1% FY 2026
ROA -35.8%
FY 2017: -52.9%FY 2018: -5.1%FY 2019: -14.0%FY 2020: -6.5%FY 2021: -14.1%FY 2022: -134.0%FY 2023: -6806777.7%FY 2024: -49.4%FY 2025: -2162.7%FY 2026: -35.8%
FY 2017 5y median -134.0% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income -4502.9%
FY 2017: -24.9%FY 2018: -208.3%FY 2019: -34.5%FY 2020: -8.5%FY 2021: -96.3%FY 2022: -396.0%FY 2023: -33215977.8%FY 2024: 100.0%FY 2025: -131.5%FY 2026: -4502.9%
FY 2017 FY 2026
EPS (diluted) 1.9%
FY 2017: -11.1%FY 2018: -110.0%FY 2019: -59.5%FY 2020: 62.7%FY 2021: -128.0%FY 2022: -278.9%FY 2023: -32652756.9%FY 2024: 100.0%FY 2025: -28.6%FY 2026: 1.9%
FY 2017 FY 2026
Free Cash Flow -67070.4%
FY 2017: 20.0%FY 2018: -271.0%FY 2019: -111.2%FY 2020: -15.4%FY 2021: -94.1%FY 2022: 23.8%FY 2023: 25.0%FY 2024: 6.5%FY 2025: 28.7%FY 2026: -67070.4%
FY 2017 FY 2026

Financial Health

Current Ratio 0.1×
FY 2017: 1.4×FY 2018: 18.0×FY 2019: 11.3×FY 2020: 6.7×FY 2021: 11.1×FY 2022: 1.5×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.0×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Quick Ratio 0.1×
FY 2017: 1.4×FY 2018: 18.0×FY 2019: 11.3×FY 2020: 6.7×FY 2021: 11.1×FY 2022: 1.5×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.0×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Debt / Equity -0.1×
FY 2017: 1.4×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -0.5×FY 2026: -0.1×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.0×
FY 2017: 0.8×FY 2018: 2.5×FY 2019: 0.7×FY 2020: 0.1×FY 2021: 0.5×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -0.0×FY 2025: -0.1×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Interest Coverage 37.0×
FY 2017: -101×FY 2018: -57.0×FY 2019: 0.0×FY 2020: -114×FY 2021: -61.6×FY 2022: -311×FY 2023: 66.4×FY 2024: 80.8×FY 2025: -260×FY 2026: 37.0×
FY 2017 5y median 37.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30